Recall Z-2782-2017— Greatbatch Medical
Class II · Terminated
Class II FDA medical device recall by Greatbatch Medical, initiated 2017-02-15, terminated 2019-05-09. It names one FDA 510(k) clearance: K130559. Product: Biosense Webster MobiCath Bi-Directional Guiding Sheath, Model D140010 (small curve) and D140011 (large curve). The MobiCath Bi-Directional Guiding Sheath is a flexible tipped percutaneous catheter introducer (or guiding sheath) designed for gaining access to the coronary systems. The device features adjustable tip geometry through use of a rotating handle to deflect the catheter. This catheter is assembled with a hemostasis valve and a sideport infusion line. The kit includes a flexible catheter dilator to facilitate bi-directional guiding sheath passage.. Reason: One side of the MobiCath Bi-Directional Guiding Sheath pouch may not be sealed..
- Recalling firm
- Greatbatch Medical
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2017-02-15
- Terminated
- 2019-05-09
- Firm location
- Plymouth, MN, United States
510(k) clearances named in this recall
1 on FDA's recordK-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.
Product description
Biosense Webster MobiCath Bi-Directional Guiding Sheath, Model D140010 (small curve) and D140011 (large curve). The MobiCath Bi-Directional Guiding Sheath is a flexible tipped percutaneous catheter introducer (or guiding sheath) designed for gaining access to the coronary systems. The device features adjustable tip geometry through use of a rotating handle to deflect the catheter. This catheter is assembled with a hemostasis valve and a sideport infusion line. The kit includes a flexible catheter dilator to facilitate bi-directional guiding sheath passage.
Reason for recall
One side of the MobiCath Bi-Directional Guiding Sheath pouch may not be sealed.
Data sourced from openFDA. This site is unofficial and independent of the FDA.